Subsequently, P1 glioma cells received treatment of lentivirus containing RBPJ shRNA (shRBPJ-Sq1 and shRBPJ-Sq2, using different sequences), leading to the establishment of stable cells after selection. Here, RBPJ is linked to central nervous system cancer.